List of articles in "Drug" category - Page 254

NNC 63-0532 is an nociceptoid drug used in scientific research. It acts as a potent and selective agonist for the nociceptin receptor also known as the ORL-1 (opiate receptor like-1) […]

Secnidazole (trade names Flagentyl Sindose Secnil) is a nitroimidazole anti-infective. Effectiveness in the treatment of dientamoebiasis has been reported. It has also been tested against Atopobium vaginae.Secnidazole is structurally related […]

C-8813 (Thiobromadol) is a potent μ-opioid agonist with a distinctive chemical structure which is not closely related to other established families of opioid drugs. The trans isomer was found to […]

R-4066 is a drug which is an analogue of the opioid analgesic methadone where the metabolically labile dimethylamino group has been replaced by a piperidinospiro group. Developed by Janssen Pharmaceutica […]

RWJ-394674 is a drug that is used in scientific research. It is a potent orally active analgesic drug that produces little respiratory depression. RWJ-394674 itself is a potent and selective […]

LY-320135 is a drug used in scientific research which acts as a selective antagonist of the cannabinoid receptor CB1. It was developed by Eli Lilly and Company in the 1990s. […]

VCHSR is a drug used in scientific research which acts as a selective antagonist of the cannabinoid receptor CB1.

Aeruginascin or NNN-trimethyl-4-phosphoryloxytryptamine is an indoleamine derivative which occurs naturally only within the mushroom Inocybe aeruginascens. Aeruginascin is the N-trimethyl analogue of psilocybin. It is closely related to the frog […]

Surinabant (SR147778) is a cannabinoid receptor type 1 antagonist developed by Sanofi-Aventis. It is being investigated as a potential treatment for nicotine addiction to assist smoking cessation.

NESS-0327 is a drug used in scientific research which acts as an extremely potent and selective antagonist of the cannabinoid receptor CB1. It is much more potent an antagonist and […]